Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 38.03%407.51M | 102.68%840.16M | 9.65%436.34M | 23.21%518.92M | -48.07%295.24M | -43.38%414.53M | -55.66%397.93M | -21.50%421.15M | -42.10%568.58M | -60.91%732.14M |
Transactional financial assets | -14.31%952.11M | -46.76%565.23M | -10.21%948.83M | -24.65%848.68M | 10.00%1.11B | 17.81%1.06B | 47.44%1.06B | 1.58%1.13B | 41.19%1.01B | --901.24M |
Notes receivable and accounts receivable | -8.58%353.34M | -3.11%350.56M | -3.72%366.61M | 0.96%384.09M | 3.56%386.51M | -3.72%361.81M | -0.19%380.75M | 4.49%380.42M | 23.60%373.24M | 41.92%375.78M |
-Notes receivable | -26.05%1.49M | 582.47%4.13M | 1.74%2.18M | -47.72%971.82K | 122.11%2.01M | -41.77%605.62K | 28.74%2.15M | 366.31%1.86M | 37.99%905.92K | 145.06%1.04M |
-Accounts receivable | -8.49%351.85M | -4.09%346.43M | -3.75%364.42M | 1.20%383.12M | 3.27%384.5M | -3.61%361.21M | -0.32%378.61M | 4.09%378.57M | 23.56%372.34M | 41.75%374.74M |
Other receivables (including interest and dividends) | -76.34%3.79M | 30.40%18.96M | 19.17%17.4M | 23.41%15.9M | 6.26%16.03M | 18.55%14.54M | 183.09%14.6M | 245.42%12.89M | 385.78%15.08M | 420.07%12.27M |
-Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Accrued interest receivable | -100.00%5.48 | 53.53%14.95M | 55.16%13.7M | 68.72%12.16M | 10.16%11.03M | 26.79%9.74M | 1,928.94%8.83M | --7.2M | 4,281.36%10.01M | --7.68M |
-Other receivable | ---- | ---- | ---- | -34.05%3.75M | ---- | 4.76%4.8M | ---- | 52.31%5.68M | --5.07M | 94.38%4.59M |
Advance payment | -11.94%17.68M | -36.42%14.65M | -81.64%9.6M | -71.18%13.34M | -57.00%20.08M | -63.28%23.04M | -8.98%52.3M | -22.96%46.28M | -10.61%46.69M | 394.33%62.75M |
Inventories | -33.87%133.9M | -35.74%129.51M | -27.80%150.69M | -7.89%185.69M | 5.10%202.49M | 19.74%201.54M | 46.74%208.71M | 57.51%201.59M | 96.86%192.66M | 117.59%168.32M |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other current assets | -21.86%9.15M | 47.67%18.06M | 134.32%14.34M | 72.21%12.77M | -79.46%11.71M | -78.24%12.23M | -89.52%6.12M | -43.72%7.41M | -19.04%57M | 122.12%56.21M |
Total current assets | -8.11%1.88B | -7.29%1.94B | -8.19%1.94B | -9.87%1.98B | -9.73%2.04B | -9.50%2.09B | -6.28%2.12B | -0.83%2.2B | 1.81%2.26B | 2.37%2.31B |
Non Current assets | ||||||||||
Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other non-current financial assets | 53.92%48.73M | 73.13%54.81M | 20.49%39.16M | -2.59%31.66M | 15.12%31.66M | 15.12%31.66M | --32.5M | --32.5M | --27.5M | --27.5M |
Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Fixed assets | ---- | ---- | ---- | 340.70%203.15M | ---- | 34.54%53.4M | ---- | 55.17%46.1M | ---- | 44.40%39.69M |
Constru in process | ---- | ---- | ---- | -86.69%5.91M | ---- | 200.71%118.43M | ---- | 108.50%44.38M | ---- | 1,686.09%39.39M |
Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Intangible assets | 10.39%10.18M | 23.20%10.52M | 11.23%7.63M | 13.84%7.93M | 27.91%9.22M | 14.19%8.54M | 7.35%6.86M | 16.12%6.96M | 16.91%7.21M | 22.01%7.47M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long deferred expense | -31.61%4.83M | -35.55%4.96M | -31.59%5.71M | -6.96%6.81M | 43.38%7.07M | 77.56%7.7M | 175.84%8.35M | 542.45%7.32M | 279.51%4.93M | 209.86%4.34M |
Deferred tax assets | 28.85%84.12M | 29.01%76.3M | 64.16%71.05M | 80.90%68.6M | 94.70%65.28M | 75.44%59.14M | 67.25%43.28M | 79.09%37.92M | 111.26%33.53M | 122.25%33.71M |
Usufruct assets | -29.89%15.45M | -27.56%16.66M | -29.01%17.99M | -25.20%20.3M | -7.43%22.03M | -1.57%22.99M | 236.10%25.34M | 429.47%27.14M | 381.80%23.8M | 347.22%23.36M |
Other non current assets | 19.29%112.54K | 132.51%219.35K | -6.30%94.34K | 0.00%94.34K | -8.26%94.34K | 0.00%94.34K | 3,923.91%100.68K | -68.75%94.34K | 9.00%102.83K | 0.00%94.34K |
Total non current assets | 15.49%370.2M | 23.29%372.28M | 53.54%351.26M | 70.17%344.45M | 76.01%320.55M | 72.01%301.96M | 102.40%228.77M | 119.46%202.41M | 209.89%182.12M | 204.23%175.55M |
Total assets | -4.91%2.25B | -3.43%2.31B | -2.17%2.3B | -3.11%2.32B | -3.34%2.36B | -3.74%2.39B | -1.10%2.35B | 3.98%2.4B | 7.17%2.45B | 7.40%2.48B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | -40.00%30M | --80M | --80M | --80M |
Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Notes payable and accounts payable | -39.63%63.33M | -13.74%95.39M | 90.75%91.04M | 81.34%105.32M | 107.75%104.9M | 45.43%110.58M | -3.78%47.73M | -27.69%58.08M | 5.24%50.49M | -8.98%76.04M |
-Notes payable | -73.08%5.91M | -59.22%7.74M | 40.53%8.73M | 554.44%11.13M | --21.94M | 373.71%18.99M | --6.21M | --1.7M | --0 | -52.50%4.01M |
-Accounts payable | -30.78%57.43M | -4.31%87.65M | 98.26%82.31M | 67.07%94.19M | 64.30%82.96M | 27.17%91.6M | -16.30%41.52M | -29.81%56.38M | 5.24%50.49M | -4.09%72.03M |
Contract liabilities | -1.88%63.5M | -6.57%69.44M | -10.46%58.25M | 2.70%65.94M | 0.65%64.71M | -7.93%74.32M | -9.85%65.05M | -19.28%64.21M | -8.98%64.29M | 16.59%80.72M |
Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Salaries payable | -15.90%17.5M | -6.76%24.94M | -12.22%22.28M | -0.13%19.31M | 12.94%20.8M | 2.91%26.75M | 11.51%25.38M | 14.81%19.33M | 23.97%18.42M | 10.09%25.99M |
Taxs payable | 0.84%9.33M | -14.74%12.48M | -30.27%6.87M | -31.11%6.98M | -35.85%9.25M | -12.40%14.63M | -36.75%9.86M | -10.67%10.13M | 52.77%14.42M | 33.59%16.71M |
Other payable (including interest and dividends) | 56.11%10M | 4.26%9M | -38.09%6.56M | -54.50%5.71M | -43.86%6.41M | -8.11%8.63M | -29.62%10.6M | 1.60%12.55M | -15.13%11.41M | -56.23%9.4M |
-Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --35K | --38.89K | --38.89K |
-Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Other payable | ---- | ---- | ---- | -54.37%5.71M | ---- | -7.73%8.63M | ---- | 1.31%12.51M | --11.37M | -56.41%9.36M |
Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non current liabilities due within one year | --5.76M | --5.94M | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other current liabilities | 7.37%4.59M | -18.87%5.44M | -22.69%4.34M | 2.56%5.53M | -14.40%4.28M | 11.09%6.71M | 8.41%5.62M | -24.33%5.39M | -33.35%5M | -24.44%6.04M |
Total current liabilities | -17.28%174.01M | -7.87%222.63M | -2.52%189.34M | -16.38%208.78M | -13.80%210.35M | -18.06%241.63M | -15.68%194.23M | 20.32%249.68M | 48.93%244.04M | 35.06%294.9M |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Deferred tax liabilities | -32.50%4.09M | -36.58%3.92M | 321.33%5.04M | 164.28%5.32M | 1,114.64%6.07M | 1.91%6.18M | --1.2M | --2.01M | --499.33K | --6.07M |
Long term deferred income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.31%7.57K | -68.31%7.57K |
Lease liabilities | -52.27%10.94M | -51.47%11.38M | -26.29%18.79M | -23.97%20.86M | -5.41%22.91M | 1.16%23.46M | 241.26%25.49M | 481.09%27.43M | 420.53%24.22M | 405.75%23.19M |
Other non current liabilities | 24.07%3.66M | 21.14%3.59M | 75.00%3.23M | 70.91%3.04M | 69.57%2.95M | 13.14%2.96M | 17.43%1.85M | 5.24%1.78M | -8.76%1.74M | 42.23%2.62M |
Total non current liabilities | -41.46%18.69M | -42.05%18.89M | -5.17%27.06M | -6.44%29.21M | 20.62%31.93M | 2.26%32.6M | 214.73%28.53M | 385.28%31.22M | 302.02%26.47M | 394.35%31.88M |
Total liabilities | -20.46%192.7M | -11.93%241.52M | -2.86%216.4M | -15.28%237.99M | -10.43%242.28M | -16.08%274.23M | -6.95%222.76M | 31.30%280.9M | 58.71%270.51M | 45.36%326.77M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M | 0.00%86.67M |
Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Capital reserve funds | 0.00%1.72B | 0.00%1.72B | -0.31%1.72B | -0.31%1.72B | -0.20%1.72B | -0.20%1.72B | -0.01%1.72B | -0.01%1.72B | 0.12%1.72B | 0.20%1.72B |
Surplus reserve funds | 11.14%41.62M | 11.14%41.62M | 13.44%37.45M | 13.44%37.45M | 13.44%37.45M | 13.41%37.45M | 31.13%33.01M | 31.13%33.01M | 31.13%33.01M | 31.16%33.02M |
Retained profit | -16.43%234.77M | -12.60%240.98M | -11.09%249.09M | -8.85%250.1M | -16.34%280.93M | -13.25%275.72M | -6.06%280.16M | 5.50%274.4M | 18.12%335.8M | 21.05%317.83M |
Less:Treasury stock | 2,514.51%26M | --19.5M | --11.33M | --6M | --994.26K | ---- | ---- | ---- | --0 | ---- |
Other composite income | 23.41%2.7M | 39.70%2.92M | -43.30%1.57M | -20.10%2.42M | 150.19%2.19M | 52.94%2.09M | 64.08%2.77M | 8,602.17%3.03M | 163.62%875.37K | 200.52%1.37M |
Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Shareholders equity without minority interests | -3.13%2.05B | -2.33%2.07B | -2.10%2.08B | -1.50%2.09B | -2.46%2.12B | -1.87%2.12B | -0.44%2.12B | 1.19%2.12B | 3.01%2.17B | 3.32%2.16B |
Minority interests | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Total shareholder equity | -3.13%2.05B | -2.33%2.07B | -2.10%2.08B | -1.50%2.09B | -2.46%2.12B | -1.87%2.12B | -0.44%2.12B | 1.19%2.12B | 3.01%2.17B | 3.32%2.16B |
Total liabilityies and equity | -4.91%2.25B | -3.43%2.31B | -2.17%2.3B | -3.11%2.32B | -3.34%2.36B | -3.74%2.39B | -1.10%2.35B | 3.98%2.4B | 7.17%2.45B | 7.40%2.48B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Zhonglian Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.